Institutional investors hold a majority ownership of EW through the 86.66% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2014, these large investors purchased a net $2.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINTON CAPITAL MANAGEMENT LTD. Bought 735.5 Thousand shares of Edwards Lifesciences Corp
AQR CAPITAL MANAGEMENT LLC Bought 705.3 Thousand shares of Edwards Lifesciences Corp